Pulmonary Consultants

Dedicated to the highest quality pulmonary and sleep healthcare

HOME

PULMONARY MEDICINE

SLEEP MEDICINE

INTERVENTIONAL MEDICINE

CRITICAL CARE

CLINICAL RESEARCH

CLINICAL RESEARCH STAFF

PROVIDERS

CLIFTON TY BAYLOR, MD

PAWAN CHAWLA, MD

ESTHER HEATH, ARNP

KURT JENSEN, MD

MANUEL G. IREGUI, MD

RICHARD A. KAHLSTROM, MD

ANN M. LEE, MD

NAVDEEP S. RAI, MD

DAVID M. SHAW, MD

JOHN T. VERRILLI, MD

BARRY J. WELED, MD

LOCATIONS & DIRECTIONS

PULMONARY - TACOMA

PULMONARY - FEDERAL WAY

PULMONARY - GIG HARBOR

SLEEP - FHS - ST. CLARE

PATIENT RESOURCES

PRESCRIPTION ASSISTANCE

PATIENT SATISFACTION SURVEY

EMPLOYMENT

SURVEYS

ABOUT US

COMMUNITY

TERMS OF USE

Location & Directions

 Call for Appointment
(253) 572-5140
or
(253)722-0435
(253)722-0461

Prescription Assistance


CLINICAL RESEARCH

Pulmonary Consultants, PLLC, located in Tacoma, Washington, is the premier pulmonary group in the Pacific Northwest.  The site employs an experienced research team of (9) board-certified Pulmonologists, (2) Nurse Practitioners, numerous Lab and Respiratory Technicians, Study Coordinators, and a Research Manager. The site is conveniently located near two major hospitals and all clinical research is done onsite.  The providers have privileges and treat patients at six hospitals in the region.  This provides a comprehensive patient population which enhances recruitment initiatives for all studies.

Our staff has extensive experience conducting Phase II-IV pharmaceutical trials, NIH-funded projects and Investigator IND research activities. Pulmonary Consultants, P.L.L.C. is currently conducting the following studies and is actively looking for Volunteers. For all our studies, study related tests and health exams will be provided at no cost. Compensation will be provided for the time and travel depending on the duration of participation.

If you would like to participate in any of these studies, please contact us at 253.722.0433 to see if you qualify.

  • Asthma
Criteria:
- Men and Women, age 18 - 65 years.
- Clinical diagnosis of persistent mild to moderate Asthma
  • Idopathic Pulmonary Fibrosis
Criteria:
- Men and Women ages 40 - 80 years.
- Diagnosis of IPF, no more than 4 years before today.
  • Grass Pollen Allergies
Criteria:
- Men and women, ages 5 - 65 years.
- Clinical history of significant grass allergies and having received treatment for the disease during the previous Grass Pollen Season.
  • COPD & Cardiac Disease
Criteria:
- Men and women, ages 40 - 80 years.
- Subjects with a current or prior history of > 10 pack-years of cigarette smoking.
- For patients >= 40 years of age: Established coronary artery disease (CAD)/peripheral vascular disease (PVD)/Previous stroke/ PreviousMI/Diabetes mellitus with target organ disease.
- For patients >= 60 years of age: any 2 of the following: Be treated for hypercholesterolemia/ hypertension/ diabetes mellitus/ peripheral vascular disease.

With more upcoming studies in these areas, we also conduct Research in other areas including Bronchoscopic Interventions, COPD, Smoking Cessation, and Sleep Disorders.

If you are a Sponsor/CRO's representative and would like to contact us about a study, please call our Research Department at 253.722.0433.


Principal Investigators
:
Richard A. Kahlstrom, M.D., Pulmonary, Critical Care
Clifton Ty Baylor, M.D., Pulmonary, Critical Care
Kurt W. Jensen, M.D., Pulmonary, Critical Care

Sub-Investigators:
Navdeep S. Rai, M.D., Pulmonary, Critical Care
Ann M. Lee, M.D., Pulmonary, Critical Care
Manuel G. Iregui, M.D., Pulmonary, Critical Care
David M. Shaw, M.D., Pulmonary, Critical Care
John T. Verrilli, M.D., Pulmonary, Critical Care
Pawan Chawla, M.D., Pulmonary, Critical Care
Esther Heath, A.R.N.P., Pulmonary, Critical Care
Lousie Dobkins, A.R.N.P., Pulmonary, Critical Care


"Advancing medical care through investigational research."

"We provide patients access to medical care and investigational study medication that may not be available at pharmacies for years to come."


© 2009-2010 Pulmonary Consultants, P.L.L.C.     |    Privacy Policy     |     Disclaimer